диссертации / 20

66.Bacaner M, Brietenbucher J, LaBree J.Prevention of ventricular fibrillation, acute myocardial infarction (myocardial necrosis), heart failure, and mortality by bretylium: is ischemic heart disease primarily adrenergic cardiovascular disease? // Am J Ther. 2004 Sep-Oct;11(5):366-411

67.Bigger JT, Fleiss JL, Steinman RC et al. Frequency domain measures of heart period variability and mortality after miokardial infarction. // Circulation 1992; 85: 164-71.

68.Bilge A.R., Jobin E., Jerard et al. Circadian variation of autonomic tone assessed by heart rate variability analysis in healthy subjects and in patients with chronic heart failure // Eur Heart J. 1998; 19(Suppl.): 369.

69.Boulanger C.M., Vanlioutte P.M. The endotelium: a modulator of cardiovascular health and disease. // Endothelium. 1999; vol. 3, № 4. -P. 187-203.

70.Brett JG, Steinberg SF, deGroot PG. Norepinephrine down-regulates the activity of protein S on endothelial cells., Nawroth PP, Stern DM. //J Cell Biol. 1988 Jun;106(6):2109-18.

71.Brunner-La Rocca H.P., Esler M.D., Jennings G.L. et al. Effect of cardiac sympathetic nervous activity on mode of death in congestive heart failure // Eur. Heart J. 2001. Vol. 22. P. 1136–1143.

72.Burger A.J., Kamalesh M., Kumar S. et al. Effect of beta adrenergic receptor blockade on cardiac autonomic tone in patients with chronic stable angina. // Pacing-Clin-Electrophysiol. 1996 Apr;19(4 Pt 1):411-417.

73.CAPRIE steering committe. A randomized, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE) // Lancet 1996; 348: 1329–39.

74.Carney RM, Freedland KE, Stein PK et al. Heart rate variability and markers of inflammation and coagulation in depressed patients with coronary heart disease. // J Psychosom Res. 2007 Apr;62(4):463-7.

131

75.Casolo G.C., Stroder P., Signorini C. et al. Heart rate variability during the acute phase of myocardial infarction. // Circulation. 1992;85:2073-2079

76.Chu SG1, Becker RC, Berger PB et al. Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta-analysis. // J Thromb Haemost. 2010 Jan; 8(1): 148-156.

77.Coleman LS. A capillary hemostasis mechanism regulated by sympathetic tone and activity via factor VIII or von Willebrand's factor may function as a

"capillary gate" and may explain angiodysplasia, angioneurotic edema, and

78. Connes P, Hue O, Hardy-Dessources MD et al. Hemorheology and heart

79.Connoly SJ, Ezekowitz MD, Yusuf S et al. Dabigatran versus warfarin in patients with atrial fibrillation. // N Engl J Med. Sep 17 2009; 361(12):11391151

80.Copie X., Hnatkova K., StauntonA. et al. Predictive Power of Increased Heart Rate Versus Depressed Left Ventricular Ejection Fraction and Heart Rate Variability for Risk Stratification After Myocardial Infarction. // J Am Coil Cardiol 2003;27:270-276

81.Cygankiwicz I., Zareba W., Vazquez R. et al. Risk stratification of mortality in patients with heart failure and left ventricular ejection fraction >35%. // Am. J. Cardiol. 2009. Vol. 103 (7). P. 1003-1010.

82.De Ferrari G.M., Crijns H.J., Borggrefe М. et al. Chronic vagus nerve

stimulation: a new and promising therapeutic approach for chronic heart failure // Eur. Heart J. 2011.Vol. 32. P. 847–855.

83. De Peuter OR, Verberne HJ, Kok WE et al. Differential effects of nonselective versus selective β-blockers on cardiac sympathetic activity and

132

hemostasis in patients with heart failure. //J Nucl Med. 2013

Oct;54(10):1733-9.

84.Dillon E, Perez CJ, Mills PJ. Effects of nonspecific beta-adrenergic stimulation and blockade on blood coagulation in hypertension. J Appl Physiol. 2003 Apr;94(4):1455-9.

85.Dunkman W.D., Johnson G.R., Carson P.F. et al. Incidenсe of thromboembolic events in congestive heart failure // Circulation. – 1993. –

Vol. 87 (Suppl. VI). – P. 94-101

86. Dünser MW, Hasibeder WR. Sympathetic overstimulation during critical illness: adverse effects of adrenergic stress. // J Intensive Care Med. 2009 Sep-Oct;24(5):293-316.

87.Eggers AE. Factor XII (Hageman factor) is a missing link between stress and hypercoagulability and plays an important role in the pathophysiology of ischemic stroke. // Med Hypotheses. 2006;67(5):1065-71.

88.Eisensehr I, Ehrenberg BL, Noachtar S et al. Platelet activation, epinephrine, and blood pressure in obstructive sleep apnea syndrome. // Neurology. 1998 Jul;51(1):188-95

89.Engler MB, Engler MM. Assessment of the cardiovascular effects of stress. // J Cardiovasc Nurs. 1995 Oct;10(1):51-63.

90.Erdogan A, Coch M, Bilgin M et al. Prognostic value of heart rate variability after acute myocardial infarction in the era of immediate reperfusion. // Elektrophysiol. 2008 Dec;19(4):161-8.

91.Falk E, Fernandez-Ortiz A. Role of thrombosis in atherosclerosis and its complications. // Am J Cardiol. 1995;75:3B–11B.

92.Fei L, Copie X, Malik M et al. Shortand long-term assessment of heart rate variability for risk stratification after acute myocardial infarction. // Am J Cardiol. 1996 Apr 1;77(9):681-4.

93.Feng DL, Tofler GH. Diurnal physiologic processes and circadian variation of acute myocardial infarction. // J Cardiovasc Risk. 1995 Dec;2(6):494-8.

133

94.Ferrari R., Ceconi C. et al. The neuroendocrine and sympathetic nervous system in congestive heart failure. // Eur. Heart.1998;19:Suppl F:45-51.

95.Flannery G., Gehrig-Mills R., Billah B. et al. Analysis of randomized controlled trials on the effect of magnitude of heart rate reduction on clinical outcomes in patients with systolic chronic heart failure receiving betablockers // Am. J. Cardiol. 2008. Vol. 101(6). P. 865–869.

96.Galinier M, Fourcade J., Androdias Ch. et al. Depressed frequency domain measures of heart rate variability as a independent predictor of sudden death in chronic heart failure // Eur Heart J. 1999; 20(Suppl.): 117.

97.Galinier M, Pathak A, Fourcade J et al. Depressed low frequency power of heart rate variability as an independent predictor of sudden death in chronic heart failure. // Eur Heart J. 2000 Mar; 21(6):475-82.

98.Gallagher M.M., Hnatkova K., Murgatroyd F.D. et al. Evolution of changes in the ventricular rhythm during paroxysmal atrial fibrillation. // Pacing- Clin-Electrophysiol. 1998 Nov;21(11 Pt 2):2450-2454.

99.Gibbs C.R., Blann A.D., Watson R.D. et al. Abnormalites of hemorheological, endothelial, and platelet function in patients with chronic heart failure in sinus rhythm: Effects of angiotensin-converting enzyme inhibitor and beta-blocker therapy // Circulation. – 2001. – Vol. 103. – P. 1746-1751.

100.Grignani G, Soffiantino F, Zucchella M et al. Platelet activation by emotional stress in patients with coronary artery disease., Pacchiarini L, Tacconi F, Bonomi E, Pastoris A, Sbaffi A, Fratino P, Tavazzi L. // Circulation. 1991 Apr;83(4 Suppl):II128-36

101.Hamaad A, Lip GY, MacFadyen RJ. Unheralded sudden cardiac death: do autonomic tone and thrombosis interact as key factors in aetiology? // Ann Med. 2003;35(8):592-604.

102.Hamaad A, Sosin MD, Blann AD et al. Markers of thrombosis and hemostasis in acute coronary syndromes: relationship to increased heart rate

134

and reduced heart-rate variability. Clin Cardiol. 2009 Apr;32(4):204-9. doi:

10.1002/clc.20321.

103.Hayano J, Kiyono K, Struzik ZR et al. Increased non-gaussianity of heart rate variability predicts cardiac mortality after an acute myocardial infarction. // Front Physiol. 2011;2:65.

104.Herweg B, Dalal P, Nagy B, Schweitcer P. Power spectral analysis of heart period variability of preceding sinus rhythm before initiation of paroxysmal atrial fibrillation. // Am J Cardiol. 1998 Oct 1;82(7):869-874

105.Hon E, Lee S. Electronic evaluation of the fetal heart rate // American Journal of Obstetrics and Gynecology. -1963. – Vol. 87. – P. 814-826.

106.Huang J.L., Wen Z.C., Lee W.L. et al. Changes of autonomic tone before the onset of paroxysmal atrial fibrillation. // Int J Cardiol. 1998 Oct 30;66(3):275-283

107.Ikeda N, Yasu T, Tsuboi K et al. Effects of submaximal exercise on blood rheology and sympathetic nerve activity. // Circ J. 2010 Apr;74(4):730-4. Epub 2010 Feb 27.

108.Iliou M. C, Zerdeni K., Prunier L. et al. Improvement of heart rate variability by exercise training in chronic heatr failure is associated with a reduction of future cardiac events. // Eur. Heart. J. – 1999. -№ 20. – Р. 118

109.Imhof A, Koenig W. Exercise and thrombosis //Cardiol Clin. 2001 Aug;19(3):389-400.

110.Jafri SM, Ozawa T, Mammen E et al. Platelet function, thrombin and

fibrinolytic activity in patients with heart failure. // Eur Heart

J. 1993 Feb;14(2):205-12.

111.Jern C, Eriksson E, Tengborn L, Risberg B, Wadenvik H, Jern S. Changes of plasma coagulation and fibrinolysis in response to mental stress. // Thromb Haemost. 1989;62:767–771.

135

112.Jiang Q, Gingles NA, Olivier MA et al. The anti-fibrinolytic SERPIN, plasminogen activator inhibitor 1 (PAI-1), is targeted to and released from catecholamine storage vesicles. // Blood. 2011 Jun 30;117(26):7155-63.

113.Jiang X, Wang Y, Hand AR. Storage and release of tissue plasminogen activator by sympathetic axons in resistance vessel walls. // Microvasc Res. 2002 Nov;64(3):438-47.

114.Jorde U.P., Vittorio T.J., Kasper M.E. et al. Chronotropic incompetence, beta-blockers, and functional capacity in advanced congestive heart failure: Time to pace? // Eur. J. Heart Fail. 2008. Vol. 10(1). P. 96–101.

115.Kiowski W, Osswald S. Circadian variation of ischemic cardiac events. // J Cardiovasc Pharmacol. 1993;21 Suppl 2:S45-8.

116.Kiviniemi AM, Tulppo MP, Wichterle D et al. Novel spectral indexes of heart rate variability as predictors of sudden and non-sudden cardiac death after an acute myocardial infarction. // Ann Med. 2007;39(1):54-62.

117.Kjeldsen SE, Weder AB, Egan B. Effect of circulating epinephrine on platelet function and hematocrit. Hypertension. 1995 May;25(5):1096-105.

118.Kleiger R. E., Miller J. P., Bigger J. T., et al. Decreased heart rate variability and its association with increased mortality after myocardial infarction. // Am. J. Cardiol. 1987, Vol.59, 256–262.

119.Koenig W. Haemostatic risk factors for cardiovascular diseases. // Eur Heart J. 1998 Apr;19 Suppl C:C39-43.

120.Kruger C., Lahm Т., Zugek C. et al. Heart rate variability enhances the

prognostic value of established parameters in patients with chronic heart

failure // Eur Heart J. 1999; 20(Suppl.): 90.

121.Lakusic N., Milicevic G., Mahovic D. et al/ Lijec. Vjesn. - 2001.- Vol. 123. - P. 120-123.

122.Landray M.J., Wheeler D.C., Lip G.Y. et al. Inflammation, endothelial dysfunction, and platelet activation in patients with chronic kidney disease:

136

the chronic renal impairment n Birmingham (CRIB) study // Am. J. Kidney

Dis. – 2004. – № 43(2). –P. 244–253.

123.Larsson PT, Wiman B, Olsson G et al. Influence of metoprolol treatment on sympatho-adrenal activation of fibrinolysis. // Thromb Haemost. 1990 Jun 28;63(3):482-7.

124.Li JJ. Circadian variation in myocardial ischemia: the possible mechanisms involving in this phenomenon. // Med Hypotheses. 2003 Aug;61(2):240-3.

125.Li XB, Guo XQ. Effect of acute hypoxia on blood catecholamine and whole blood platelet aggregation. // Sheng Li Xue Bao. 1996 Oct;48(5):45763.

126.Lip G.Y., Gibbs C.R., Blann A.D. et al. Abnormalities of hemorheological, endothelial, and platelet function in patients with chronic heart failure in sinus rhythm: effects of angiotensin-converting enzyme inhibitor and beta-blocker therapy // Circulation. – 2001. – № 103(13). – P. 1746–1751.

127.Lip G.Y.H., Ponikowski P., Andreotti F., et al. Thromboembolism and antithrombotic therapy for heart failure in sinus rhythm. A joint consensus document from the ESC Heart Failure Association and the ESC Working Group on Thrombosis // Eur. J. Heart. Fail. – 2012. – № 14(7). – P. 681–

695.

128.Loh E., Sutton M.I., Wun C.C. et al. Ventricular dysfunction and the risk of stroke after myocardial infarction // New Engl. J. Med. – 1997. – Vol. 336. – P. 251-257.

129.Luscher T.F. Endothelial dysfunction as a therapeutic target: the ENCORE trials. //Europ. Heart J. 2000; vol. 2; (Suppl. D); P. 20-26. 207

130.Malliani A, Montano N. Sympathetic overactivity in ischaemic heart disease.// Clin Sci (Lond). 2004 Jun;106(6):567-8.

137

131.Maron BJ, Poliac LC, Roberts WO. Risk for sudden cardiac death associated with marathon running. // J Am Coll Cardiol. 1996;28:428–431.

132.Maron BJ. Sudden death in young athletes. // N Engl J Med. 2003;349:1064–1075.

133.Mischler K, Fischer JE, Zgraggen L et al. The effect of repeated acute mental stress on habituation and recovery responses in hemoconcentration and blood cells in healthy men. // Life Sci. 2005 Jul 22;77(10):1166-79. Epub 2005 Apr 26.

134.Moreno PR, Bernardi VH, Lopez-Cuellar J et al. Macrophages, smooth muscle cells, and tissue factor in unstable angina. Implications for cell-mediated thrombogenicity in acute coronary syndromes. // Circulation. 1994;94:3090–3097.

135.Moussouttas M, Bhatnager M, Huynh TT et al. Association between sympathetic response, neurogenic cardiomyopathy, and venous thromboembolization in patients with primary subarachnoid hemorrhage. // Acta Neurochir (Wien). 2013 Aug;155(8):1501-10.

136.Nakamura T, Ariyoshi H, Kambayashi J et al. Effect of low concentration of epinephrine on human platelet aggregation analyzed by particle counting method and confocal microscopy. // J Lab Clin Med. 1997 Sep;130(3):238-9.

137.Nolan, J. Andrews, R., Brooksby, P. Relationship between heart rate variability and mode of death in chronic heart failure: results of the UKHEART study // Eur. Heart J. – 1997. – 18(Suppl.). – Р. 577.

138.Nygren A, Redfors B, Thorén A, Ricksten SE. Norepinephrine causes a pressure-dependent plasma volume decrease in clinical vasodilatory shock. Acta // Anaesthesiol Scand. 2010 Aug;54(7):814-20.

139.O’Connor C.M., Gurbel P.A., Serebruany V.L. Usefullnes of sobuble

and surface-bound P-selectin in defecting heightened platelet activity in

138

patients with congestive heart failure // Amer. J. Cardiology. – 1999. – Vol.

83.– P. 1345-1349.

140.Odemuyiwa O, Farrell TG, Malik M et al. Influence of age on the relation between heart rate variability, left ventricular ejection fraction, frequency of ventricular extrasystoles, and sudden death after myocardial infarction. // Br Heart J. 1992 May;67(5):387-91.

141.Odemuyiwa O., Malik M., Farrell T. et al. Comparison of the Predictive Characteristics of Heart Rate Variability Index and Left Ventricular Ejection Fraction for All-Cause Mortality, Arrhythmic Events and Sudden Death After Myocardial Infarction. // Am J Cardiol 1991;68:434-439

142.Otowa K, Takamura M, Murai H et al. Altered interaction between plasminogen activator inhibitor type 1 activity and sympathetic nerve activity with aging. // Circ J. 2008 Mar;72(3):458-62

143.Ozdemir O, Alyan O, Soylu M. Relation between sympathetic overactivity and left atrial spontaneous echo contrast in patients with mitral stenosis and sinus rhythm. // Heart Lung Circ. 2006 Aug;15(4):242-7.

144.Packer M., Coats A.J.S., Fowler M.B. et al. Effect of carvedilol on survival in severe heart failure. N. Eng.Med 2001;344:1651-1658.

145.Рathak, A, Fourecade, J, Castel, A. Approach of theautonomic nervouse system in chronic heart failure: is QT dynamicity better than heart rate variability? // Eur. Heart J. –2000. – 21 (Suppl.). – Р. 331.

146.Perkiömäki JS, Jokinen V, Tapanainen J et al. Autonomic markers as

predictors of nonfatal acute coronary events after myocardial infarction. // Ann Noninvasive Electrocardiol. 2008 Apr;13(2):120-9.

147. Petidis K, Douma S, Doumas M et al. The interaction of vasoactive substances during exercise modulates platelet aggregation in hypertension and coronary artery disease. // BMC Cardiovasc. Disord.,Vol. 27, No. 8, p. 11

139

148.Philip C. S., Kesson M., Daisy L. et al. Pathophysiological processes underlying emotional triggering of acute cardiac events. // Proc Natl Acad Sci U S A. 2006 Mar 14;103(11):4322-7.

149.Pickering TG. Mental stress as a causal factor in the development of hypertension and cardiovascular disease.// Curr Hypertens Rep. 2001;3(3):249-54.

150.Pinelli A, Trivulzio S, Rossoni G. Activated partial thromboplastin time correlates with methoxyhydroxyphenylglycol in acute myocardial infarction patients: therapeutic implications for patients at cardiovascular risk. // In Vivo. 2014 Jan-Feb;28(1):99-104.

151.Pipilis A., Flather M., Ormerod O. et al. Heart Rate Variability in Acute Myocardial Infarction and Its Association with Infarct Site and Clinical Course. // Am J Cardiol. 1991;67:1137-1139.

152.Pitsilos S, Hunt J, Mohler ER et al. Platelet factor 4 localization in carotid atherosclerotic plaques: Correlation with clinical parameters. // Thromb Haemost. 2003;90:1112–1120.

153.Ponikovski, P., Anker S.D., Chua T.P. Depressed heart rate variability is an independent predictor of death in patients with chronic heart failure // Eur. Heart J. –1997. – 18(Suppl.). – Р. 577.

154.Poole-Wilson P.A., Swedberg K., Cleland J.F.C. et.al. Comparison of carvedilol and metaprolol on clinical outcomes in patients with chronic heart failure. Carvedilol or Metaprolol European Trial (COMET) randomized controlled trial. Lancet 2003;362:7-13.

155.Pöyhönen-Alho M, Joutsi-Korhonen L, Lassila R et al. Alterations of sympathetic nervous system, coagulation and platelet function in gestational diabetes. // Blood Coagul Fibrinolysis. 2012 Sep;23(6):508-13.

156.Remme W. J. ACE inhibition in ischemic heart disease: what is the relevance of the control of the neuroendocrine response? //Dialogues in

Cardiovascular Medicine. 2000; vol. 5; № 2; P. 98 - 107.

140